Literature DB >> 9205124

Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin.

L de Lecea1, P Ruiz-Lozano, P E Danielson, J Peelle-Kirley, P E Foye, W N Frankel, J G Sutcliffe.   

Abstract

Cortistatin is a 14-residue putative neuropeptide with strong structural similarity to somatostatin and is expressed predominantly in cortical GABAergic interneurons of rats. Administration of cortistatin into the brain ventricles specifically enhances slow-wave sleep, presumably by antagonizing the effects of acetylcholine on cortical excitability. Here we report the identification of cDNAs corresponding to mouse and human preprocortistatin and the mRNA distribution and gene mapping of mouse cortistatin. Analysis of the nucleotide and predicted amino acid sequences from rat and mouse reveals that the 14 C-terminal residues of preprocortistatin, which make up the sequence that is most similar to somatostatin, are conserved between species. Lack of conservation of other dibasic amino acid residues whose cleavage by prohormone convertases would give rise to additional peptides suggests that cortistatin-14 is the only active peptide derived from the precursor. As in the rat, mouse preprocortistatin mRNA is present in GABAergic interneurons in the cerebral cortex and hippocampus. The preprocortistatin gene maps to mouse chromosome 4, in a region showing conserved synteny with human 1p36. The human putative cortistatin peptide has an arginine for lysine substitution, compared to the rat and mouse products, and is N-terminally extended by 3 amino acids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9205124     DOI: 10.1006/geno.1997.4763

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  16 in total

1.  Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

Authors:  Y Coulouarn; I Lihrmann; S Jegou; Y Anouar; H Tostivint; J C Beauvillain; J M Conlon; H A Bern; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 2.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

3.  Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin.

Authors:  P Cassoni; G Muccioli; T Marrocco; M Volante; E Allia; E Ghigo; R Deghenghi; M Papotti
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

4.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

Authors:  L de Lecea; T S Kilduff; C Peyron; X Gao; P E Foye; P E Danielson; C Fukuhara; E L Battenberg; V T Gautvik; F S Bartlett; W N Frankel; A N van den Pol; F E Bloom; K M Gautvik; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

5.  Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.

Authors:  Nabil A Elshourbagy; Stephen A Douglas; Usman Shabon; Stephen Harrison; Graham Duddy; Jan L Sechler; Zhaohui Ao; Beverly E Maleeff; Diane Naselsky; Jyoti Disa; Nambi V Aiyar
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

Review 6.  New roles of a neuropeptide cortistatin in the immune system and cancer.

Authors:  Min Li; Shaoyu Yan; William E Fisher; Changyi Chen; Qizhi Yao
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

7.  Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.

Authors:  A Benso; C Gottero; F Prodam; C Gauna; S Destefanis; L Filtri; A J van der Lely; R Deghenghi; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

8.  Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families.

Authors:  Hervé Tostivint; Lucille Joly; Isabelle Lihrmann; Caroline Parmentier; Alexis Lebon; Mireille Morisson; André Calas; Marc Ekker; Hubert Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-07       Impact factor: 11.205

9.  The evolution of vertebrate somatostatin receptors and their gene regions involves extensive chromosomal rearrangements.

Authors:  Daniel Ocampo Daza; Görel Sundström; Christina A Bergqvist; Dan Larhammar
Journal:  BMC Evol Biol       Date:  2012-11-29       Impact factor: 3.260

10.  Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.